The Lancet HIV in conversation with
Duración total:
15 h 39 min
Janet Turan and Zachary Kwena on home-based couples testing and counselling for HIV
The Lancet HIV in conversation with
23:12
Amy Justice and Keri Althoff on the Lancet HIV Commission on ageing and HIV
The Lancet HIV in conversation with
22:45
Annemarie Wensing, Tommaso Clemente, and Arjen Stam on clinical management of persistent low-level viremia in people on antiretroviral therapy
The Lancet HIV in conversation with
19:02
David Coelho and Arjee Restar on mental health disparities among transgender women and transfeminine people living with HIV
The Lancet HIV in conversation with
29:56
Esteban Martinez and Steven Grinspoon on non-communicable diseases and the REPRIEVE trial
The Lancet HIV in conversation with
25:54
Colette Smith on the Positive Voices UK survey recording health needs of people living with HIV
The Lancet HIV in conversation with
13:59
Eran Shorer on Parkinsonism in people with virally suppressed HIV
The Lancet HIV in conversation with
19:24
Solange Baptiste, Charles Holmes, and Kenneth Ngure on sustainable HIV prevention in Africa
The Lancet HIV in conversation with
43:18
Luxena Sukumaran and Alan Winston on disordered sleep in people living with HIV
The Lancet HIV in conversation with
21:04
Deborah Persaud on the possibility of HIV remission in neonates
The Lancet HIV in conversation with
35:39
Jayne Ellis on cytomegalovirus and Epstein–Barr virus in people with HIV-associated cryptococcal meningitis
The Lancet HIV in conversation with
17:25
Maggie Walters and Michelle Bulterys on the probability of vertical transmission of HIV
The Lancet HIV in conversation with
18:33
Mansoor Farahani, Wafaa El-Sadr, and Wilford Kirungi on the progress in the HIV response in Uganda
The Lancet HIV in conversation with
25:16
Richard Wu on a phase 1 trial of a broadly neutralising antibody for HIV
The Lancet HIV in conversation with
16:23
Grace Lui and Vincent Wong on lifestyle modifications to address MASLD in people with HIV
The Lancet HIV in conversation with
13:50
Debra ten Brink and Rowan Martin-Hughes on the effects of international aid cuts on HIV acquisitions and mortality
The Lancet HIV in conversation with
24:00
Sari Reisner on the benefits of gender-affirming hormone therapy on HIV clinical outcomes
The Lancet HIV in conversation with
21:28
Lisa Noguchi and Nyaradzo Mgodi on HIV prophylactic dapivirine ring in breastfeeding women
The Lancet HIV in conversation with
23:02
Sharon Lewin on requirements of a cell- and gene-based therapy product for HIV cure
The Lancet HIV in conversation with
24:59
Claudia Cortes y Giovanni Ravasi sobre VIH y migración (in Spanish)
The Lancet HIV in conversation with
33:29
Florence Riako Anam and Bruce Richman on U=U
The Lancet HIV in conversation with
25:53
Peter Hayward on 10 years of The Lancet HIV
The Lancet HIV in conversation with
23:22
Salome Kuchukidze and Souleymane Diabaté on the link between intimate partner violence and vertical HIV transmission in sub-Saharan Africa
The Lancet HIV in conversation with
24:19
José M. Zuniga on the future of urban HIV responses Commission
The Lancet HIV in conversation with
22:47
Alejandro García sobre los tiempos de transición en la atención médica continuada del VIH en España (ES)
The Lancet HIV in conversation with
25:41
Serge Eholie on treatments for HIV-2
The Lancet HIV in conversation with
26:45
Drew Voetsch and Robert Selato on achieving the 95-95-95 UNAIDS goals in Botswana
The Lancet HIV in conversation with
22:13
Adam Trickey on trends in causes of death among people with HIV in Europe and North America
The Lancet HIV in conversation with
11:58
Manik Kohli, Iain Reeves, and Laura Waters on homophobia in the provision of sexual health care in the UK
The Lancet HIV in conversation with
41:51
Lulu Nair, Connie Celum, and Kenneth Ngure on dapivirine vaginal ring and daily oral PrEP for HIV prevention in women
The Lancet HIV in conversation with
15:08
Sophia Rein on HIV treatment with INSTIs and cardiovascular events
The Lancet HIV in conversation with
15:15
Lawrence Mbuagbaw on reporting of HIV drug resistance in clinical studies using the CEDRIC-HIV checklist
The Lancet HIV in conversation with
09:23
Andreas Jahn and Nellie Wadonda-Kabondo on trends in HIV prevalence and incidence
The Lancet HIV in conversation with
24:14
Eryn Braley and Mckenzie Braley on experiences of HIV among global Indigenous populations
The Lancet HIV in conversation with
21:20
Ricardo Luque and Miguel Barriga on HIV prevalence and care continuum among migrants from Venezuela in Colombia (en Español)
The Lancet HIV in conversation with
45:07
Denton Callander on the effects of treatment as prevention
The Lancet HIV in conversation with
18:59
Andrea Wirtz and Sari Reisner on HIV incidence and mortality among transgender women
The Lancet HIV in conversation with
26:05
Yasmin Mohamed on early infant diagnosis of HIV
The Lancet HIV in conversation with
17:24
Salome Kuchukhidze and Francisco Mbofana on intimate partner violence and women with HIV
The Lancet HIV in conversation with
22:46
Lise Jamieson and Gesine Mayer-Rath on cabotegravir for PrEP in South Africa
The Lancet HIV in conversation with
26:03
